JPH0430398B2 - - Google Patents
Info
- Publication number
- JPH0430398B2 JPH0430398B2 JP22839683A JP22839683A JPH0430398B2 JP H0430398 B2 JPH0430398 B2 JP H0430398B2 JP 22839683 A JP22839683 A JP 22839683A JP 22839683 A JP22839683 A JP 22839683A JP H0430398 B2 JPH0430398 B2 JP H0430398B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- nucleoside
- phosphate
- group
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002777 nucleoside Substances 0.000 claims description 17
- 150000003833 nucleoside derivatives Chemical class 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 8
- -1 monomethoxytrityl group Chemical group 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 2
- 150000003230 pyrimidines Chemical class 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000007086 side reaction Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- JWKMDCBKGBDVKK-HFASVGIHSA-N 1-[(2s,4s,5r)-4-hydroxy-5-(methylperoxymethyl)-2-trityloxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](COOC)O[C@@]1(C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C=1C=CC=CC=1)N1C(=O)NC(=O)C(C)=C1 JWKMDCBKGBDVKK-HFASVGIHSA-N 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 3
- 230000000865 phosphorylative effect Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- 229940045145 uridine Drugs 0.000 description 2
- DRVMZMGCPWFDBI-UHFFFAOYSA-N 2,2,2-trifluoroethyl dihydrogen phosphate Chemical compound OP(O)(=O)OCC(F)(F)F DRVMZMGCPWFDBI-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- IESPNWVSLUTLPN-UHFFFAOYSA-N bis(2,2,2-trifluoroethyl) phosphite Chemical compound FC(F)(F)COP([O-])OCC(F)(F)F IESPNWVSLUTLPN-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003536 tetrazoles Chemical group 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Description
本発明は新規なヌクレオシド3'‐ホスフエート
の製造方法に関するものであり、さらに詳しくは
一般式〔〕
(式中、Rは水素原子または水酸基を示し、Aは
モノメトキシトリチル基またはジメトキシトリチ
ル基を示し、Bは
The present invention relates to a novel method for producing nucleoside 3'-phosphates, more specifically, the general formula [] (In the formula, R represents a hydrogen atom or a hydroxyl group, A represents a monomethoxytrityl group or a dimethoxytrityl group, and B represents a
【式】で表わさ
れる2,6,8位に置換基を有することもあるプ
リン核またはA purine nucleus that may have substituents at the 2, 6, and 8 positions represented by [Formula] or
【式】で表わされる2,
4,5位に置換基を有することもあるピリミジン
核を示す)
で表わされるヌクレオシドと、一般式〔〕
〔CF3(CH2)oO〕2POH 〔〕
(式中、nは1〜3の整数である)
で表わされるジアルキルホスフアイトを溶媒中で
加熱下反応させ、得られた一般式〔〕
(式中、R、A、Bは前記の意味を持つ)
で表わされるヌクレオシド3'‐ホスフアイトを酸
化してホスフエートを得ることを特徴とする一般
式〔〕
で表わされるヌクレオシド3'‐ホスフエートの新
規な合成法に関するものである。ヌクレオシド
3'‐ホスフエートは遺伝子工学上重要な出発原料
となり、現在までに種々の合成法が開発されてき
たが、まだ満足できるものは得られていない。例
えば4‐フロロフエニルホスホロジトリアゾール
〔R.W.Adamiak etal.Nucleic Acid Ress.3、
3397(1976)]、ホスホロモノテトラゾール[H.
Takakn etal Chem Lett 192(1982)]などのホ
スホリル化剤を用いた合成方法が公知であるが、
これらの方法ではグアノシンやウリジンの塩基部
へのホスホリル化が副反応として起こる。さらに
縮合剤を用いた合成法では縮合剤としてのアリー
ルスルホニルがグアノシンやウリジンの塩基部又
は水酸基に導入される副反応が起こる。
〔P.R Bridson etal J.C.S.Chem.447,791,
(1977)〕この様に現在用いられている方法では何
らかの副反応が起こつているので得られる目的生
分物の純度が悪く収率も低いのであまり好ましい
ものとは言えない。
そこで我々はヌクレオシド3'‐ホスフエートの
製造の際に副反応の起こらない合成法を開発する
ために鋭意研究を重ねた結果ある種のジアルキル
ホスフアイトを原料ヌクルオシドのホスホリル化
剤として用いるとこの目的に適合することを見い
出した。このホスホリル化剤はトリアゾール、テ
トラゾールおよび縮合剤などの活性基を用いるこ
とがないので、本発明によるホスホリル化剤を用
いたヌクレオシド3'‐ホスフエートの製造方法は
副反応の生起を心配する必要がなくしかも高収率
でヌクレオシド3'‐ホスフエートが生成する利点
を有している。すなわち、本発明は前述したよう
な当該技術分野の要望にこたえ、かつ従来方法の
欠点を克服した新規なヌクレオシド3'‐ホスフエ
ートの製造方法を提供するものである。次に本発
明の反応経路を示すと次の通りである:
(式中、R、A、Bは前記の意味を持つ)
本発明はヌクレオシド〔〕に対して好ましく
は1〜3当量のジアルキルホスフアイト〔〕を
加え、溶媒中加熱下又好ましくは窒素ガス雰囲気
下で反応させ、ヌクレオシド3′‐ホスフアイト
〔〕を得る。その後酸化剤を加え処理すると化
合物〔〕が酸化されて対応するヌクレオシド
3′‐ホスフエート〔〕が高収率で得られる。
〔〕と〔〕の反応における溶媒としてはピ
リジンなどの塩基性溶媒、ベンゼン、トルエンな
どの芳香族炭化水素溶媒、アセトンなどのケトン
系溶媒、酢酸エチルエステルなどのエステル系溶
媒、ジエチルエーテルなどのエーテル系溶媒があ
げられる。又反応温度は25〜80℃、好ましくは40
〜60℃である。化合物〔〕から〔〕への反応
における酸化剤としては過酸化水素、過安息香
酸、ヨウ素などが用いられる。酸化剤の量はヌク
レオシドに対して好ましくは3〜6当量が用いら
れる。上記一般式〔〕〔〕〔〕の化合物で使
用される置換基Bは式The nucleoside represented by the general formula [] [CF 3 (CH 2 ) o O] 2 POH [] ( (wherein n is an integer of 1 to 3) A dialkyl phosphite represented by the following is reacted in a solvent under heating, resulting in the general formula [] (In the formula, R, A, and B have the above-mentioned meanings) A general formula characterized in that a phosphate is obtained by oxidizing a nucleoside 3'-phosphite represented by [] This paper relates to a new method for synthesizing nucleoside 3'-phosphate represented by nucleosides
3'-phosphate has become an important starting material for genetic engineering, and various synthetic methods have been developed to date, but none have yet been found to be satisfactory. For example, 4-fluorophenylphosphoroditriazole [RWAdamiak etal. Nucleic Acid Ress.3,
3397 (1976)], phosphoromonotetrazole [H.
Synthesis methods using phosphorylating agents such as Takakn etal Chem Lett 192 (1982) are known;
In these methods, phosphorylation of guanosine or uridine to the base moiety occurs as a side reaction. Furthermore, in the synthesis method using a condensing agent, a side reaction occurs in which the arylsulfonyl condensing agent is introduced into the base moiety or hydroxyl group of guanosine or uridine. [PR Bridson etal JCSChem.447, 791,
(1977)] As described above, in the methods currently used, some side reactions occur, resulting in poor purity of the desired product and low yield, so it cannot be said to be very preferable. Therefore, we have conducted extensive research to develop a synthetic method that does not cause side reactions during the production of nucleoside 3'-phosphate, and as a result, we have found that using a certain type of dialkyl phosphite as a phosphorylation agent for the raw material nucleoside can be used for this purpose. I found that it fits. Since this phosphorylating agent does not use active groups such as triazole, tetrazole, and condensing agents, the method for producing nucleoside 3'-phosphates using the phosphorylating agent according to the present invention does not need to worry about side reactions. Moreover, it has the advantage of producing nucleoside 3'-phosphate in high yield. That is, the present invention provides a novel method for producing nucleoside 3'-phosphates that meets the needs of the technical field as described above and overcomes the drawbacks of conventional methods. Next, the reaction route of the present invention is shown as follows: (In the formula, R, A, and B have the above-mentioned meanings.) In the present invention, preferably 1 to 3 equivalents of dialkyl phosphite [] are added to the nucleoside [], and the mixture is heated in a solvent or preferably in a nitrogen gas atmosphere. The reaction is performed below to obtain nucleoside 3'-phosphite. Then, when an oxidizing agent is added and treated, the compound [] is oxidized and the corresponding nucleoside
3′-phosphate [ ] is obtained in high yield. Solvents for the reaction between [] and [] include basic solvents such as pyridine, aromatic hydrocarbon solvents such as benzene and toluene, ketone solvents such as acetone, ester solvents such as acetic acid ethyl ester, and ethers such as diethyl ether. Examples include solvents. The reaction temperature is 25 to 80℃, preferably 40℃.
~60℃. Hydrogen peroxide, perbenzoic acid, iodine, etc. are used as the oxidizing agent in the reaction from compound [] to []. The amount of oxidizing agent used is preferably 3 to 6 equivalents relative to the nucleoside. The substituent B used in the compound of the above general formula [] [] [] is of the formula
【式】で表
わされる2,6,8位に置換基を有することもあ
るプリン該または式Purine that may have substituents at the 2, 6, and 8 positions represented by [Formula] or the formula
【式】で表わされる
2,4,5位に置換基を有することもあるピリミ
ジン該をそれぞれ示すが、プリン該での2,6位
置換基は水素原子、アルキル基またはアシル基で
置換されることもあるアミノ基またはケト基を示
し、8位は水素原子であるかまたはハロゲン原子
で置換されている。ピリミジン該での2、4位置
換基はアルキル基またはアシル基で置換されるこ
ともあるアミノ基またはケト基を示し、5位置換
基は水素原子であるかまたはアルキル基、ハロゲ
ン原子またはシアノ基を示す。ここでアルキル基
とは炭素数1〜3の飽和炭化水素結合鎖を表わ
す。
以上述べた様に、本発明により、活性基を用い
ずにホスホリル化する試薬を使つたスクレオシド
3'‐ホスフエートの合成法は他にその例を見ない
ものであり、副反応も起こらず選択的に高収率で
目的物の得られることは該酸の化学、農薬の分野
に重要な技術的進歩を与えるものである。
次に本発明の代表的な合成法を実施例によつて
詳述する。
実施例 1
5'‐o‐モノメトキシトリチルチミジン3'‐
(トリフルオロエチル)ホスフエートの合成
5'‐o‐モノメトキシトリチルチミジン
(MMTrT)(0.515g、1.0mmol)をピリジン
(7ml)に溶解し、ビス(2,2,2‐トリフル
オロエチル)ホスフアイト(0.46ml、3mmol)
を加え、窒素ガス雰囲気下50℃にて3時間反応さ
せたのち、反応液を室温まで冷却し、さらに0℃
まで冷却し、m‐クロロ過安息香酸(1.04g、6
mmol)を加えて10分間処理すると生成物は酸化
されホスフエートとなる。反応液を氷水(5ml)
に加え、塩化メチレン(10ml)で抽出した後、有
機層を5%NaHCO3(5ml×3)さらに水(5ml
×2)で洗浄する。塩化メチレンを減圧除去し、
さらに少量のトルエンを加え、ピリジン臭が無く
くなるまで減圧をくり返す。残渣を少量の塩化メ
チレンに溶解し、激しく撹拌しているヘキサン‐
エーテル(10:1)中へ加えると白色の沈澱が生
じ、これを取すると5′‐o‐モノメトキシトリ
チルチミジン3′‐(トリフルオロエチル)ホスフ
エート(m.p=148〜150℃℃)が0.69g得られた。
得られた生成物の物性値は次の通りである。
Rf=0.01(CH2C2:CH3OH=9:1);
Rf=0.97((CH3)2CO:H2O=7:3);
UV;λMeOH nax=265、260nm;
λMeOH nio=247、226nm。
実施例 2
5′‐o‐ジメトキシトリチルベンゾイルデオキ
シミチジン3′‐(トリフルオロエチル)ホスフ
エートの合成
5′‐o‐ジメトキシトリチルベンゾイルデオキ
シミジン(d‐DMTrCbz)(0.664g、1.0mmol)
を使用する以外は実施例1と同様に反応処理して
相当する5′‐o‐ジメトキシトリチルベンゾイル
デオキシチミジン3'‐(トリフルオロエチル)ホ
スフエート(mp=112〜114℃)が0.781g(90
%)得られた。得られた生成物の物性値は次の通
りである。
Rf=0.11(CH2C2:CH3OH=9:0);
Rf=0.97((CH3)2CO:H2O=7:3);
UV:λMeOH nax=304、275、235nm;
λMeOH nio=289、249nm。
これらの化合物の化学構造は保護基を完全に脱
保護した後、酵素分解し、その化学構造を確認し
た。なお上記実施例1および2に準じる具体例を
表1に要約して示す。[Formula] These are pyrimidines that may have substituents at the 2, 4, and 5 positions, but the substituents at the 2, 6 positions of purine are substituted with hydrogen atoms, alkyl groups, or acyl groups. sometimes an amino group or a keto group, the 8th position being a hydrogen atom or substituted by a halogen atom. The substituents at the 2 and 4 positions of pyrimidine are an amino group or a keto group which may be substituted with an alkyl group or an acyl group, and the substituent at the 5 position is a hydrogen atom or an alkyl group, a halogen atom, or a cyano group. shows. Here, the alkyl group represents a saturated hydrocarbon bond chain having 1 to 3 carbon atoms. As described above, according to the present invention, screoside production using a reagent that phosphorylates without using an active group.
The method for synthesizing 3'-phosphate is unique, and the ability to selectively obtain the desired product in high yield without side reactions is an important technology in the fields of acid chemistry and agrochemicals. It is something that gives you a lot of progress. Next, typical synthetic methods of the present invention will be explained in detail with reference to Examples. Example 1 5'-o-monomethoxytritylthymidine 3'-
Synthesis of (trifluoroethyl) phosphate 5'-o-monomethoxytrityl thymidine (MMTrT) (0.515 g, 1.0 mmol) was dissolved in pyridine (7 ml) and bis(2,2,2-trifluoroethyl) phosphite ( 0.46ml, 3mmol)
was added and reacted for 3 hours at 50°C under a nitrogen gas atmosphere, then the reaction solution was cooled to room temperature and further heated to 0°C.
m-chloroperbenzoic acid (1.04 g, 6
mmol) and treated for 10 minutes, the product is oxidized to phosphate. Pour the reaction solution into ice water (5 ml)
After extraction with methylene chloride (10 ml), the organic layer was mixed with 5% NaHCO 3 (5 ml x 3) and water (5 ml).
Wash with ×2). Remove methylene chloride under reduced pressure,
Add a small amount of toluene and repeat the vacuum until the pyridine odor disappears. The residue was dissolved in a small amount of methylene chloride and dissolved in hexane with vigorous stirring.
When added to ether (10:1), a white precipitate formed, which was removed to yield 0.69 g of 5'-o-monomethoxytritylthymidine 3'-(trifluoroethyl) phosphate (mp = 148-150°C). Obtained. The physical properties of the obtained product are as follows. Rf = 0.01 (CH 2 C 2 : CH 3 OH = 9:1); Rf = 0.97 ((CH 3 ) 2 CO: H 2 O = 7:3); UV; λ MeOH nax = 265, 260 nm; λ MeOH nio = 247, 226nm. Example 2 Synthesis of 5'-o-dimethoxytritylbenzoyldeoxymitidine 3'-(trifluoroethyl)phosphate 5'-o-dimethoxytritylbenzoyldeoxymitidine (d-DMTrC bz ) (0.664 g, 1.0 mmol)
The reaction was carried out in the same manner as in Example 1 except that 0.781 g (90
%) obtained. The physical properties of the obtained product are as follows. Rf=0.11 (CH 2 C 2 :CH 3 OH=9:0); Rf=0.97 ((CH 3 ) 2 CO:H 2 O=7:3); UV: λ MeOH nax = 304, 275, 235 nm; λ MeOH nio = 289, 249 nm. The chemical structures of these compounds were confirmed by completely deprotecting the protecting groups and then enzymatically decomposing them. Note that specific examples similar to Examples 1 and 2 above are summarized in Table 1.
【表】【table】
Claims (1)
モノメトキシトリチル基またはジメトキシトリチ
ル基を示し、Bは【式】で表わさ れる2,6,8位に置換基を有することもあるプ
リン核または【式】で表わされる2, 4,5位に置換基を有することもあるピリミジン
核を示す) で表わされるヌクレオシドと、 一般式[] 〔CF3(CH2)oO〕2POH 〔〕 (式中nは1〜3の整数である) で表わされるジアルキルホスフアイトを反応さ
せ、得られたヌクレオシド3'‐ホスフアイトを酸
化してホスフエートにすることを特徴とするヌク
レオシド3'‐ホスフエートの製造方法。[Claims] 1. General formula [] (In the formula, R represents a hydrogen atom or a hydroxyl group, A represents a monomethoxytrityl group or a dimethoxytrityl group, and B represents a purine nucleus that may have substituents at the 2, 6, and 8 positions represented by the formula) or a pyrimidine nucleus that may have a substituent at the 2, 4, or 5 positions represented by the formula] and a nucleoside represented by the general formula [] [CF 3 (CH 2 ) o O] 2 POH [] (In the formula, n is an integer of 1 to 3) The production of a nucleoside 3'-phosphate characterized by reacting a dialkyl phosphite represented by the formula and oxidizing the obtained nucleoside 3'-phosphite to a phosphate. Method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22839683A JPS60120897A (en) | 1983-12-05 | 1983-12-05 | Production of novel nucleoside 3'-phosphate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22839683A JPS60120897A (en) | 1983-12-05 | 1983-12-05 | Production of novel nucleoside 3'-phosphate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60120897A JPS60120897A (en) | 1985-06-28 |
| JPH0430398B2 true JPH0430398B2 (en) | 1992-05-21 |
Family
ID=16875808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP22839683A Granted JPS60120897A (en) | 1983-12-05 | 1983-12-05 | Production of novel nucleoside 3'-phosphate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60120897A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0291088A (en) * | 1988-09-29 | 1990-03-30 | Central Glass Co Ltd | Phosphite and nucleoside-3'-phosphite derivative and synthesis of oligonucleotide using the same |
| CN112409421A (en) * | 2020-12-01 | 2021-02-26 | 上海兆维科技发展有限公司 | Preparation method of 3' -phosphate nucleoside |
-
1983
- 1983-12-05 JP JP22839683A patent/JPS60120897A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60120897A (en) | 1985-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5341956B2 (en) | Boranophosphate monomer | |
| JPH0631305B2 (en) | Nucleoside derivative | |
| NZ225944A (en) | Biotinylated polynucleotides and analogues thereof, processes for their preparation and intermediates therefor | |
| CN114409706A (en) | Preparation method of phenyl hydrogen phosphonate and intermediate thereof | |
| JPS6072899A (en) | Manufacture of nucleosidoalkyl-, aralkyl- and allyl-phosphonite and -phosphonate | |
| EP0351126B1 (en) | Process for the production of 02,2'-anhydro-1-(beta-D-arabinofuranosyl)thymine | |
| WO2013126034A1 (en) | Synthesis of high purity dmt-c3-disulfide phosphoramidite | |
| JPH0430398B2 (en) | ||
| JPH0291088A (en) | Phosphite and nucleoside-3'-phosphite derivative and synthesis of oligonucleotide using the same | |
| Hancox et al. | Some reactions of 4′-thionucleosides and their sulfones | |
| JPS5841896A (en) | Decyanoethylation of protected nucleotide | |
| JPH0372235B2 (en) | ||
| KR102703062B1 (en) | Novel tetra-substituted diphosphate-based compound and method for preparing the same | |
| JPH04164090A (en) | Phosphorylating agent and method for forming phosphodiester bond using the same | |
| US5254691A (en) | Phosphorylating agent and method for forming phosphodiester bond using the same | |
| JPH0588240B2 (en) | ||
| Kato et al. | Highly chemo-and regioselective phosphitylation of unprotected 2′-deoxyribonucleosides | |
| PL179560B1 (en) | Method for the production of asymmetric phosphoric acid diesters | |
| Dabkowski et al. | Synthesis of phosphorofluoridates and phosphorofluoridothioates via the phosphoramidite approach | |
| GB2096596A (en) | 8-quinolinesulfonyl derivatives and their synthesis and use as coupling agents in nucleotide chemistry | |
| JP4814084B2 (en) | Boranophosphate monomer and method for producing oligonucleotide derivative using the same | |
| KR820001887B1 (en) | Process for preparing n-triryl imidazole compounds | |
| JPH0368594A (en) | Production of polynucleotide | |
| CN118946572A (en) | Synthesis of isomerically pure polyol-based phosphoramidites | |
| TAKAKU et al. | A comparative study on phosphate protecting groups in oligonucleotide synthesis by the phosphotriester approach |